Comprehensive service for discovering and identifying new cancer biomarkers in human serum and plasma samples to advance precision medicine and diagnostics.
Manufactured by
Berlin, Germany
Since 1999, we have been innovating in the diagnostics space to make a healthier world. From being a Native Antigen manufacturer, we have substantially enhanced our portfolio over the years to become a premium provider of IVD raw materials and pre-clinical drug discovery services. Our relentless passion to make a healthier world drives us to continually focus on the emerging unmet needs in the diagnostics space and become the preferred partner to our customers worldwide.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
PreceDo Pharmaceuticals Co.Ltd.
China · 2 relevant products
Anhui Yisheng Medical Technology Co., Ltd
China · 1 relevant product
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 78 closest product alternatives
BioChain (Beijing) Science & Technology. Inc. · China
A targeted blood-based early detection service for specific cancer types utilizing gene methylation biomarkers. This clinical testing service is performed by BioChain's certified medical laboratory.
BioChain (Beijing) Science & Technology. Inc. · China
A comprehensive blood-based screening service designed to detect multiple cancer types simultaneously through gene methylation analysis. This service utilizes advanced NGS technology and is available as a clinical testing service.
PreceDo Pharmaceuticals Co.Ltd. · China
A high-throughput drug sensitivity testing platform utilizing renewable primary cancer cells to predict treatment response. This service enables personalized treatment selection through comprehensive chemotherapy and targeted drug profiling.
75 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products